Affymetrix Shares Plunge as Firm Sees Loss

Praecis shares fall after FDA fails to approve new drug application; Merrill downgrades Research in Motion; plus other stocks in the news

Nokia ( NOK ) sees Q2 sales growth below 10%, earnings per ADR of EUR 0.15-0.17. S&P maintains its accumulate rating. CS First Boston cut its estimates on Nokia.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.